Orthobiologics Market Growth, Demand and Challenges of the Key Industry Players 2027

1
Global Orthobiologics Market Research and
Forecast Report 2022-2027




Author Elena Anderson Marketing Manager IMARC
Group
2022 IMARC All Rights Reserved
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2
About IMARC Group
Report Description
International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all regions
and industry verticals to identify their
highest-value opportunities, address their most
critical challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Orthobiologics Market Research Report
2022-2027 According to the latest report by
IMARC Group, titled "Orthobiologics Market
Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2022-2027," the global
orthobiologics market size reached US 5.4
Billion in 2021. Orthobiologics are prescription
drugs made by living organisms to heal orthopedic
tissues. Some of the common orthobiologics
include bone marrow concentrate, platelet-rich
plasma (PRP), birth tissues and certain fat
grafts. These are autologous or allogeneic
substances that are injected or placed surgically
toacceleratethe healing of bones, joints,
muscles, or tendons.Nowadays, platelet-rich
plasma (PRP) is a rapidly gaining tractionin the
field of regenerative medicine, showing excellent
potential in triggering or expediting the healing
process in bones, muscles and ligaments. Request
for a PDF sample of this report
https//www.imarcgroup.com/orthobiologics-market/r
equestsample

4
Report Description and Highlights
Report Description
Global Orthobiologics Market Trends The market
is primarily driven by the increasing prevalence
of osteoarthritis(OA), especially among the
geriatric population. Older adultsare also highly
susceptible to spinal and other orthopedic
disorders, resulting in the need foran increased
number of orthopedic procedures. Besides this,
the rising awareness among physicians and
patients aboutthe benefits oforthobiologic
therapies and newly introduced treatment
procedures and technologies have encouraged them
to opt for orthobiologics. Moreover, extensive
investments and collaborations by prominent
medical device and biotechnology companies in the
research and development (RD) to produce
advanced orthobiologics are providing a positive
market outlook. Some of the other factors,
including the growing preference for minimally
invasive (MI) procedures, improving healthcare
infrastructure and advent of next-generation
biologics technology, are also contributing to
the market growth. Looking forward, the market
is anticipated to grow at a CAGR of 5.27 during
the forecast period (2022-2027). View Report
TOC, Figures and Tables https//www.imarcgroup.co
m/orthobiologics-market

5
Report Description and Highlights
Report Description

• Key Market Segmentation
• The research report includes the following
  segments
• Breakup by Product
• Demineralized Bone Matrix
• Allograft
• Bone Morphogenetic Protein
• Viscosupplementation Products
• Synthetic Bone Substitutes
• Others
•  
• Breakup by Type
• Knee
• Ankle
• Hip
• Wrist and Shoulder
• Spine
• Others

6
Report Description and Highlights
Report Description

• Breakup by Application
• Osteoarthritis and Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial and Dental Applications
•  
• Breakup by End User
• Hospitals and Ambulatory Centers
• Research and Academic Institutes
• Dental Clinics and Facilities
• Orthopedic Clinics
• Breakup by Region
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

7
Report Description and Highlights
Report Description

•  
• Competitive Landscape with Key Players
• Arthrex Inc
• Globus Medical Inc
• Integra LifeSciences
• Johnson Johnson
• Medline Industries Inc
• Medtronic plc
• NuVasive Inc
• Orthofix Medical Inc
• Smith Nephew plc
• Stryker Corporation
• Terumo Corporation
• Wright Medical Group N.V
• Zimmer Biomet
•  

8
Key Questions Answered in the Report
Report Description

• How has the global orthobiologics market
  performed so far and how will it perform in the
  coming years?
• What has been the impact of COVID-19 on the
  global orthobiologics market?
• What are the key regional markets?
• What is the breakup of the market based on the
  product?
• What is the breakup of the market based on the
  type?
• What is the breakup of the market based on the
  application?
• What is the breakup of the market based on the
  end user?
• What are the various stages in the value chain of
  the industry?
• What are the key driving factors and challenges
  in the industry?
• What is the structure of the global
  orthobiologics market and who are the key
  players?
• What is the degree of competition in the
  industry?
•  

9
Table of Contents
Report Description
1    Preface2    Scope and Methodology    2.1
   Objectives of the Study    2.2  
 Stakeholders    2.3    Data Sources       
2.3.1    Primary Sources        2.3.2  
 Secondary Sources    2.4    Market Estimation 
      2.4.1    Bottom-Up Approach        2.4.2  
 Top-Down Approach    2.5    Forecasting
Methodology3    Executive Summary4  
 Introduction    4.1    Overview    4.2    Key
Industry Trends5    Global Orthobiologics
Market    5.1    Market Overview    5.2  
 Market Performance    5.3    Impact of
COVID-19    5.4    Market Forecast

10
Table of Contents
Report Description
6    Market Breakup by Product    6.1  
 Demineralized Bone Matrix        6.1.1 Market
Trends        6.1.2 Market Forecast    6.2  
 Allograft        6.2.1 Market Trends       
6.2.2 Market Forecast    6.3    Bone
Morphogenetic Protein        6.3.1 Market
Trends        6.3.2 Market Forecast    6.4  
 Viscosupplementation Products        6.4.1
Market Trends        6.4.2 Market Forecast   
6.5     Synthetic Bone Substitutes        6.5.1
Market Trends        6.5.2 Market Forecast     
    Click here to visit the complete table of
content with list of figures and tables
https//www.imarcgroup.com/orthobiologics-market/t
oc

11
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
12
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
13
Report Description and Highlights
Report Description

2022 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
14

Contact Us